Scientists say their new insights into how a key brain protein works could help resolve a long-standing question in molecular ...
Biohaven's troriluzole candidate for spinocerebellar ataxia (SCA) has been turned down by the FDA, causing shares in the company to lose more than 40% of their value in pre-market trading. The news is ...
After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU. Skyclarys ...
The registry is a contact list of individuals with cerebellar ataxia who are willing to be contacted for participation in research studies and clinical trials. When signing up, you will fill out some ...